株価
11.10
毎日の変更
-0.09 -0.80%
毎月
10.56%
毎年
51.02%
Q2 予測
10.32




貿易債権者 変化する 日付
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Akebia Therapeutics USD 21.18M 11.1M 2025-12
ALKERMES USD 102.36M 5.59M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Exelixis USD 29.62M 4.27M 2025-12
Immunic USD 10.14M 2.22M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
MacroGenics USD 4.79M 1.15M 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Prothena USD 5.88M 4.63M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xoma USD 2.65M 1.52M 2025-09